Centrient
Sustainable leader in antibiotics, statins and anti-fungals
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs).
First established in 1869, our story has since been one of constant evolution and innovation. Today, we are a company 2,700-people strong with operations on four continents.
More than this, we are a pharmaceutical company with a clear mission: to improve lives by being at the centre of sustainable and accessible healthcare.
Our company has a common focus that unites each of us in our mission: across our global operations, we are committed to ensuring Quality, Reliability and Sustainability to customers, partners, patients and the world at large.
Moving forward, our vision is to be the leading, diversified and fully integrated partner to generics marketers.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
€1 million subsidy for sustainable egg alternative: Kick-off of project EGGcellent at Planet B.io
During a celebratory event on Friday, April 11, at Planet B.io in Delft, Meindert Stolk, Regional Minister for Economy and Innovation of the Province of South Holland, awarded a ~€1 million subsidy cheque to the EGGcellent project. This regional innovation initiative brings together the innovative companies Vivici, Proeon and Applikon, along with Planet B.io, which will focus on developing a sustainable, vegan alternative to chicken eggs, specifically for use in the bakery industry. The funding comes from the “Kansen voor West III” program, supported by the European Regional Development Fund (ERDF).
Meet the new faces of Planet B.io
The Planet B.io team is growing! We’re excited to welcome three new colleagues who will strengthen our biotech innovation ecosystem: Mohammed Iaallala (Senior Manager Strategic Relations), Natascha Keijzer (Lab Manager), and Katri Kaunismaa (Subsidy Manager). Each of them brings valuable expertise to help our community grow, whether through strategic partnerships, lab management, or funding opportunities.
Planet B.io welcomes GenScript and Lesaffre
Planet B.io and ASR Dutch Science Park Fund are very happy to announce that two new companies have joined the Planet B.io community on the Biotech Campus Delft from April 1st on.